» Articles » PMID: 22411427

Operant, Oral Alcoholic Beer Self-administration by C57BL/6J Mice: Effect of BHF177, a Positive Allosteric Modulator of GABA(B) Receptors

Overview
Specialty Pharmacology
Date 2012 Mar 14
PMID 22411427
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: With its high palatability, near-beer has been successfully used in rats as a vehicle to induce ethanol oral self-administration.

Objectives: The study aimed to develop an operant model of oral alcoholic beer self-administration promoting a stable intake of pharmacologically relevant amounts of ethanol in free-feeding C57BL/6J mice. It also aimed to assess the model's predictive validity by evaluating the influence of baclofen, a GABA(B) agonist, and BHF177, a GABA(B) positive allosteric modulator, on alcoholic beer self-administration.

Methods: Mice were trained to self-administer, under a fixed ratio three schedule of reinforcement, 10 μl of beer containing increasing ethanol concentrations (0-18% v/v) in daily 30-min sessions. The effects on motor coordination (rotarod), locomotor activity (open field, automated cages) and anxiety-like behavior (elevated plus maze, EPM) were examined. Baclofen (1.25-5 mg/kg, intraperitoneal, i.p.) and BHF177 (3.75-30 mg/kg, i.p.) were used to see the effects on 9% alcoholic beer and near-beer self-administration.

Results: Near-beer stably maintained operant oral self-administration in mice. Adding ethanol to near-beer reduced the number of active lever presses, while the corresponding amount of ethanol self-administration increased (0.8-1.0 g/kg/session). Motor impairment was observed when more than 1.3 g/kg/session of ethanol was self-administered with beer and slight but consistent hyperlocomotion with more than 0.9-1.0 g/kg/session. BHF177 (15 mg/kg) preferentially reduced 9% alcoholic beer self-administration, while the higher dose (30 mg/kg)-like baclofen 5 mg/kg-also reduced near-beer self-administration.

Conclusions: The operant model of oral alcoholic beer self-administration in C57BL/6J mice should prove useful for studying ethanol-reinforced behaviors and to identify candidate compounds for the pharmacological management of alcohol addiction.

Citing Articles

BHF177 Suppresses Diabetic Neuropathic Pain by Blocking PKC/CaMKII/ERK1/2/CREB Signaling Pathway through Activating GABA Receptor.

Liu B, Guan F, Zhao J, Niu Y, Jiang H Oxid Med Cell Longev. 2022; 2022:4661519.

PMID: 36439691 PMC: 9691330. DOI: 10.1155/2022/4661519.


GABA Receptors and Alcohol Use Disorders: Preclinical Studies.

Holtyn A, Weerts E Curr Top Behav Neurosci. 2020; 52:157-194.

PMID: 32808090 DOI: 10.1007/7854_2020_178.


Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.

Viudez-Martinez A, Garcia-Gutierrez M, Fraguas-Sanchez A, Torres-Suarez A, Manzanares J Br J Pharmacol. 2018; 175(16):3369-3378.

PMID: 29859012 PMC: 6057893. DOI: 10.1111/bph.14380.


Pre- and postnatal exposure to moderate levels of ethanol can have long-lasting effects on hippocampal glutamate uptake in adolescent offspring.

Brolese G, Lunardi P, de Souza D, Lopes F, Leite M, Goncalves C PLoS One. 2015; 10(5):e0127845.

PMID: 25978644 PMC: 4433332. DOI: 10.1371/journal.pone.0127845.


GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence.

Agabio R, Colombo G Front Neurosci. 2014; 8:140.

PMID: 24936171 PMC: 4047789. DOI: 10.3389/fnins.2014.00140.


References
1.
Maccioni P, Colombo G . Role of the GABA(B) receptor in alcohol-seeking and drinking behavior. Alcohol. 2009; 43(7):555-8. DOI: 10.1016/j.alcohol.2009.09.030. View

2.
Quertemont E, Tambour S, Bernaerts P, Zimatkin S, Tirelli E . Behavioral characterization of acetaldehyde in C57BL/6J mice: locomotor, hypnotic, anxiolytic and amnesic effects. Psychopharmacology (Berl). 2004; 177(1-2):84-92. DOI: 10.1007/s00213-004-1911-x. View

3.
McGregor I, Saharov T, Hunt G, Topple A . Beer consumption in rats: the influence of ethanol content, food deprivation, and cocaine. Alcohol. 1999; 17(1):47-56. DOI: 10.1016/s0741-8329(98)00033-0. View

4.
Pothos E, Creese I, Hoebel B . Restricted eating with weight loss selectively decreases extracellular dopamine in the nucleus accumbens and alters dopamine response to amphetamine, morphine, and food intake. J Neurosci. 1995; 15(10):6640-50. PMC: 6578017. View

5.
Ebenezer I . Intraperitoneal administration of baclofen increases consumption of both solid and liquid diets in rats. Eur J Pharmacol. 1995; 273(1-2):183-5. DOI: 10.1016/0014-2999(94)00707-e. View